The Cephalexin Capsules, cataloged under National Stock Number 6505-01-724-0531, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Teva Pharmaceuticals Usa, Inc.. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-724-0531 |
| Primary Part Number | NDC00093-3147-01 |
| Item Name | Cephalexin Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Teva Pharmaceuticals Usa, Inc. |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Type | BOTTLE, PLASTIC |
| Capsule Type | HARD |
| Active Medicament Medicinal Strength | 500.0 MILLIGRAMS CEPHALEXIN ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00093-3147-01 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| 326561 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM249934 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1674964 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-724-0531 is a Cephalexin Capsules, manufactured by Teva Pharmaceuticals Usa, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-724-0531 has 2 manufacturer part numbers on file: NDC00093-3147-01 (Teva Pharmaceuticals Usa, Inc.), 326561 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office).
Key specifications for NDC00093-3147-01: Administration: ORAL; Primary Container Type: BOTTLE, PLASTIC; Special Features: USED TO TREAT INFECTIONS CAUSED BY BACTERIA, INCLUDING UPPER RESPIRATORY INFECTIONS, EAR INFECTIONS, SKIN INFECTIONS, URINARY TRACT INFECTIONS AND BONE INFECTIONS, IT WORKS BY FIGHTING BACTERIA IN YOUR BODY; STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE); DISPENSE IN A TIGHT, LIGHT-RESISTANT CONTAINER; BOTTLE OF 100 CAPSULES, 500MG.; Capsule Type: HARD. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.